![Page 1: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/1.jpg)
Lifestyle diseases in People living with HIV
Nombulelo MagulaNelson R Mandela School of Medicine
University of KwaZulu-Natal
![Page 2: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/2.jpg)
![Page 3: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/3.jpg)
• Exposure over many decades• Unhealthy diets• Smoking • Lack of exercise• Stress
• Major risk factors• High blood pressure• High blood cholesterol• Diabetes• obesity
Diseases of Lifestyle
![Page 4: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/4.jpg)
Lifestyle diseases in 2005
• 2/3 deaths globally were attributable to CDL.
• 35 million deaths from CDL recorded were double the number of
deaths
• for all infectious diseases (HIV/AIDS, tuberculosis, malaria),
• maternal and perinatal conditions, and
• nutritional deficiencies combined.
![Page 5: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/5.jpg)
• Approximately 4/5 CDL deaths occurred in low and middle-income
countries with the main ones being
• heart disease
• stroke
• cancer
• chronic respiratory diseases and
• diabetes
![Page 6: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/6.jpg)
![Page 7: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/7.jpg)
![Page 8: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/8.jpg)
![Page 9: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/9.jpg)
• Smoking is projected to kill 50% more people in 2015 than HIV/AIDS,
and
• Will be responsible for 10% of all deaths globally.
![Page 10: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/10.jpg)
World’s largest ART program
IHD among top 3 causes of death in HIV infected population in
2030 in low income countries
Mathers C, Loncar D. Plos Med. 2006; 3:e442
![Page 11: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/11.jpg)
To determine:•Prevalence•Incidence•Predictors
of diabetes and dysglycaemia in South African black patients.
![Page 12: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/12.jpg)
![Page 13: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/13.jpg)
![Page 14: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/14.jpg)
Eligibility• Prospective designStudy group1. 2nd generation Zulu2. Age >18 years 3. ART naïve 4. Starting ART5. Informed consent
• Cross sectional designStudy group1. HIV infected2. 2nd generation Zulu3. Age > 18years 4. ART naïve 5. Informed consent
Controls1. Age, gender and ethnically matched HIV negative volunteers
![Page 15: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/15.jpg)
Outcomes:
A. lipodystrophy development (by FRAM questionnaire
B. Development of:
i. Fat re-distribution (by CT scan and Dexa scan measures)
ii. Diabetes and dysglycaemia
iii. Dyslipidaemia
iv) Other metabolic changes
At 0, 3, 6, 12, 18 and 24 months
HIV+
Starting ART
Baseline, 3, 6, 12, 18 and 24 months;
1. ART outcomes
2. Examine incidence and determinants of lipodystrophyDiabetes and
dysglycaemia in HIV infected vs control (HIV-) group
Volunteers
group 3
HIV +
Starting ART
group 2
HIV +
Not starting ART
group 1
HIV negative
Participants presenting at KEH and VCT centers in Durban
Study Design Flow DiagramStep 2: Prospective
Step 1: Cross-sectional
![Page 16: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/16.jpg)
Methods
• Outcomes• Diabetes• Impaired glucose
tolerance (IGT)• Impaired fasting glucose
(IFG)• Dysglycaemia=
Diabetes or IGT or IFG (Any disorder of glycaemia)
• History • Physical examination• Anthropometry
• Circumferences• Skin folds
• Oral glucose tolerance test• 0 hour plasma glucose (after
overnight fast) and • 2 hour plasma glucose (after
ingestion of 75g glucose monohydrate dissolved in 250 ml water
• HbA1c
• Laboratory tests• Fat distribution
• DXA scan• CT scan
![Page 17: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/17.jpg)
WHO and ADA diagnostic criteria for diabetes and other disorders of glycaemia
Category WHO ADA
Diabetes
HbA1c > 6.5 % or > 6.5 % or
Plasma glucose (PG):
Fasting or > 7.0 mmol/l > 7.0 mmol/l
2-h post glucose load > 11.1 mmol/l > 11.1 mmol/l
Impaired Glucose tolerance (PG)
Fasting (if measured) and
<7.0 mmol/l
2-h post glucose load > 7.8 mmol/l 7.8 – 11.0 mmol/l
Impaired Fasting glucose (PG)
Fasting > 6.1 and < 7.0 mmol/l 5.6 – 6.9 mmol/l
and (if measured) 2-h post glucose load
<7.8 mmol/l
![Page 18: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/18.jpg)
Study Enrolment Flow Chart
Screened, n=530 Not Eligible, n=204:Failure to return after
screening, n=120 Not second generation Zulu,
n=16 Consent refused, n=12 History of ART, n=20 Tuberculosis, n=27 Malignancy, n=3
Died before starting ART, n=1Pregnant, n=4
Wishes to fall pregnant, n=1
Eligible, n=326
Group 1 HIV negative
n=88
Group 2 HIV infected, not
starting ART n=88
Group 3 HIV infected, starting ART
n=150
![Page 19: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/19.jpg)
Variable Group 1HIV - n=88
Group 2HIV + not starting ART, n=88
Group 3HIV + starting ART, n=150
p
Age (yr) 37.0 + 14.5
37.6 + 9.1 36.9 + 9.1 ns
Female 58 (65.9) 58 (65.9) 102 (68.0) Marital status (single) 61(69.3) 67 (79.8) 112(76.7) nsHigh school education 61(70.1) 63(74.1) 98(69.0)
ns
Employed 19 (30.2) 24(37.5) 59(41.3) nsTobacco smoking 18 (20.7) 18 (21.2) 24 (17.9) nsAlcohol 29 (34.1) 33 (38.8) 40 (27.0) 0.01Physical activity Occupational: moderate 32 (40.0) 26 (31.7) 37 (30.6)
ns
Leisure: moderate 9 (10.7) 10 (12.2) 15 (10.6) ns
Familial diabetes 17 (19.3) 18 (21.2) 36 (24.3) ns
Demographic characteristics at baseline*
* n (%) or Mean + SD
![Page 20: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/20.jpg)
Clinical and laboratory characteristics at baseline
Variable Group 1HIV - n=88
Group 2HIV + not starting ART, n=88
Group 3HIV + starting ART, n=150
p
Systolic BP (mmHg) 118.9 + 21.8 115.66 + 17.2 112.1 + 16.8 0.02
Diastolic BP (mmHg) 72.9 + 12.5 72.36 + 11.2 70.9 + 10.7 ns
Body mass index(kg/m2) 29.1 + 7.9 28.6 + 7.8 26.4 + 6.2 0.01
Plasma glucose (mM)
0 – min 5.0 + 0.9 4.8 + 0.4 4.8 + 0.4 ns
120 – min 5.6 + 2.3 4.8 + 1.3 5.2 + 1.1 nsHbA1c (%) 3.97 + 0.7 3.95 + 0.6 3.98 + 0.7 ns
CD4 cell count, cells/mm3 - 404.5(343 - 531) 132(64 - 193) 0.0001
Log HIV RNA - 4.33 + 0.93 4.75 + 0.92 0.002
![Page 21: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/21.jpg)
HIV negative HIV infected not starting
ART
HIV infected starting ART
0
2
4
6
8
10
12
4.9
0 0
3.7
2.42.96
0
1.20.7
8.6
3.7 3.7
WHO criteriaDiabetes IGT IFG Dysglycaemia
%
Prevalence of diabetes and dysglycaemia
HIV negative HIV infected not starting
ART
HIV infected starting ART
4.9
0 0
3.7
2.42.96
3.7 3.6 3.7
11.1
6.16.6
ADA criteria
****
**p<0.01 D group 3 vs. group 1
![Page 22: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/22.jpg)
Multivariate analysis
Variable OR (95% CI) p
Systolic blood pressure 1.07 (1.02 to 1.12) 0.003
Serum triglyceride 4.5 (1.03 to 19.8) 0.04
![Page 23: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/23.jpg)
Overall response rate of Group 3 (HIV infected and starting ART)
24 Months
Baseline
n =150
Not followed-up
n = 53
(35.0%)
Follow-up complete
n = 97
(64.7%)
![Page 24: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/24.jpg)
Prospective - Step 2Antiretroviral treatment allocation*
*n(%)
Variable
All patients
n=150
Male
n=48
Female
n=102 p
Efavirenz 76 (50.7) 40 (83.3) 36 (35.3) <0.0001
Nevirapine 74 (49.3) 8 (16.7) 66(64.7) <0.0001
Lamivudine 150 (100.0) 48 (100.0) 102 (100.0) -
Tenofovir 150 (100.0) 48 (100.0) 102 (100.0) -
![Page 25: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/25.jpg)
Baseline characteristics of Group 3 subjects: completed vs. not completed 24 month visit follow-up
Variable 24 month follow-up complete
n=9724 month follow-up
incompleten=53 p
Age 37.5 + 9.1 36.0 + 9.3 ns
Female 64 (65.98) 38 (71.7) ns
Marital Status: Single 71 (73.2) 41 (77.4) nsHigh school 64 (70.3) 34 (66.7) nsEmployed 47 (50.5) 12 (24) 0.002Body mass index 26.6 + 5.9 26.1 + 6.7 ns CD4 cell count(cells/mm3) 142 + 82.6 135.2 + 97.5 ns log HIV RNA load 4.7 + 1.0 4.9 + 0.8 ns Haemoglobin 11.3 + 1.9 10.8 + 2.1 ns Albumin 34.9 + 5.0 33.4 + 6.3 ns Efavirenz 49 (50.5) 27 (50.9) ns Nevirapine 48 (49.5) 26 (49.1) ns Tenofovir 97 (100.0) 53 (100.0) - Lamivudine 97 (100.0) 53 (100.0) -
![Page 26: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/26.jpg)
Immunological and Virological response during 24 months follow up on ART
0 3 6 12 18 240
50
100
150
200
250
300
350
400
0
1
2
3
4
5
6
CD4 Cell Count HIV RNA Load
month
Cells
/mm
3
log
p < 0.0001
p < 0.0001
![Page 27: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/27.jpg)
* OGTT criteria
Incidence of Diabetes Mellitus*during 24 months follow up on ART
n PYFU Incidence rate
5 221.9 (150) 2.3 (0.7 to 5.3)
![Page 28: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/28.jpg)
n PYFU Incidence rate
16 211.6 (150) 7.6 (4.3 to 12.3)
Incidence of Dysglycaemia (Diabetes or IGT or IFG)* during 24 months follow up on ART
* OGTT criteria
![Page 29: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/29.jpg)
Baseline characteristics : Group 3 (n:150)developed diabetes vs. not developed diabetes*
VariableDeveloped Diabetes
n=5
Not developed Diabetes n= 145
p
Age (yr) 39.8+6.1 36.8+9.3 0.5
Male 4 (80.0) 44 (30.3) 0.02
Efavirenz 5 (100.0) 71 (47.9) 0.02
BP (mmHg)
Systolic 126.8+17.4 111.4+16.6 0.04
Diastolic 84.8+12.1 70.3+10.4 0.003
BMI (kg/m2) 25.6+6.9 26.3+6.2 0.6
*by OGTT
![Page 30: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/30.jpg)
Baseline characteristics :Group 3 (n:150):developed vs. not developed dysglycaemia
VariableDeveloped
dysglycaemia, n=16
Not developed dysglycaemia,
n=134p
Age 41.1+6.97 36.3+9.3 0.03
Male 9 (56.3) 37 (28.5) 0.03
Efavirenz 12 (75.0) 64(47.8) 0.04
Nevirapine 4 (25.0) 70(52.2) 0.04
BP (mmHg)
Systolic 124.2+19.2 110.6+15.97 0.002
Diastolic 77.8+11.7 70.2+10.5 0.01
![Page 31: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/31.jpg)
World’s largest ART program
Prevalence of diabetes
HbA1c criteria
HIV negative: 1.2 %
HIV infected: 0%
Prevalence of diabetes
(glucose-based criteria)
HIV negative: 4.9%
HIV infected: 0%
Prevalence of dysglycaemia
HIV negative: 8.6%
HIV infected: 3.7%
![Page 32: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/32.jpg)
World’s largest ART program
IR of dysglycaemia
7.6 per 100 PYFU
(95% CI [4.3 to 12.3])
IR of diabetes (glucose-based criteria)
2.3 per 100 PYFU (95% CI[0.7 to 5.3])
IR rate of diabetes (HbA1c criteria) 3.8 per 100 PYFU (95% CI [1.6 to 7.4])
![Page 33: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/33.jpg)
Multivariate analysis
Diabetes Dysglycaemia
Variable HR (95% CI) pVisceral: subcutaneous fat
2.95 (1.25 to 6.96) 0.01Variable HR (95% CI) p
Systolic BP 1.04 (1.01 to 1.06) 0.002
Albumin 0.84 (0.8 to 0.9) 0.002
CD 4 cell count 0.988 (0.980 to 0.997) 0.01
Efavirenz 3.98 (1.29 to 14.8) 0.02
![Page 34: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/34.jpg)
WIHS: 2.8*
D: A:D: 0.5*
SWISS: 4.4*
MACS: 4.7* D: A:D: 0.5*
D: A:D: 0.5*D: A:D: 0.5*
APROCO-COPILOTE:1.4*
Incidence rate studies of Diabetes or dysglycaemia in HIV infected patients on cART
*incidence rate/100 PYFU
KZN: 2.3*Justman,et.al. 2003De Wit,et.al. 2008Brown, et.al. 2005Ledergerber, et.al. 2007Capeau, et.al. 2012
![Page 35: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/35.jpg)
Conclusion
• Prevalence of diabetes 0% prior to cART
• Incidence of diabetes and dysglycaemia on cART is high
• Monitoring for diabetes and dysglycaemia in patients on cART warranted
• Probably the first study reporting efavirenz as a predictive risk factor for incident dysglycaemia
• Alternative to Efavirenz as the backbone of cART needs to be considered
![Page 36: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/36.jpg)
Clinical and laboratory characteristics at baseline
Variable Group 1HIV - n=88
Group 2HIV + not starting ART, n=88
Group 3HIV + starting ART, n=150
p
Systolic BP (mmHg) 118.9 + 21.8 115.66 + 17.2 112.1 + 16.8 0.02
Diastolic BP (mmHg) 72.9 + 12.5 72.36 + 11.2 70.9 + 10.7 ns
Body mass index(kg/m2) 29.1 + 7.9 28.6 + 7.8 26.4 + 6.2 0.01
Plasma glucose (mM)
0 – min 5.0 + 0.9 4.8 + 0.4 4.8 + 0.4 ns
120 – min 5.6 + 2.3 4.8 + 1.3 5.2 + 1.1 nsHbA1c (%) 3.97 + 0.7 3.95 + 0.6 3.98 + 0.7 ns
CD4 cell count, cells/mm3 - 404.5(343 - 531) 132(64 - 193) 0.0001
Log HIV RNA - 4.33 + 0.93 4.75 + 0.92 0.002
![Page 37: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/37.jpg)
0 3 6 12 18 240
102030405060708090
weight (kg) BMI(kg/m2)
months
p<0.0001
p<0.0001
0 3 6 12 18 24405060708090
100110120130
Systolic BP Diastolic BP
months
mm
Hg
p<0.0001
p=0.05
Clinical characteristicsduring 24 months
follow-up on ART
![Page 38: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/38.jpg)
![Page 39: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/39.jpg)
![Page 40: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/40.jpg)
![Page 41: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/41.jpg)
![Page 42: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/42.jpg)
![Page 43: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/43.jpg)
![Page 44: Lifestyle diseases in People living with HIV Nombulelo Magula Nelson R Mandela School of Medicine University of KwaZulu-Natal](https://reader031.vdocument.in/reader031/viewer/2022013012/5697c0131a28abf838cccd89/html5/thumbnails/44.jpg)